p.102 抽出テキスト

349. Kikuta Y, Cook CM, Sharp ASP, Salinas P, Kawase Y, Shiono Y, et al. Pre-angioplasty instantaneous wave-free ratio pullback predicts hemodynamic outcome in humans with coronary artery disease. JACC Cardiovasc Interv 2018;11:757–67. https://doi.org/ 10.1016/j.jcin.2018.03.005 350. Jeremias A, Davies JE, Maehara A, Matsumura M, Schneider J, Tang K, et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary intervention: the DEFINE PCI study. JACC Cardiovasc Interv 2019;12: 1991–2001. https://doi.org/10.1016/j.jcin.2019.05.054 351. Lee SH, Shin D, Lee JM, Lefieux A, Molony D, Choi KH, et al. Automated algorithm using pre-intervention fractional flow reserve pullback curve to predict postintervention physiological results. JACC Cardiovasc Interv 2020;13:2670–84. https:// doi.org/10.1016/j.jcin.2020.06.062 352. Omori H, Kawase Y, Mizukami T, Tanigaki T, Hirata T, Kikuchi J, et al. Comparisons of nonhyperemic pressure ratios: predicting functional results of coronary revascularization using longitudinal vessel interrogation. JACC Cardiovasc Interv 2020;13:2688–98. https://doi.org/10.1016/j.jcin.2020.06.060 353. Masdjedi K, Tanaka N, Van Belle E, Porouchani S, Linke A, Woitek FW, et al. Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study. EuroIntervention 2022;17:1498–505. https://doi.org/10.4244/eij-d-21-00471 354. Scoccia A, Byrne RA, Banning AP, Landmesser U, Van Belle E, Amat-Santos IJ, et al. Fractional flow reserve or 3D-quantitative-coronary-angiography based vessel-FFR guided revascularization. Rationale and study design of the prospective randomized fast III trial. Am Heart J 2023;260:1–8. https://doi.org/10.1016/j.ahj.2023.02.003 355. Song L, Xu B, Tu S, Guan C, Jin Z, Yu B, et al. 2-Year outcomes of angiographic quantitative flow ratio-guided coronary interventions. J Am Coll Cardiol 2022;80:2089–101. https://doi.org/10.1016/j.jacc.2022.09.007 356. Johnson NP, Matsuo H, Nakayama M, Eftekhari A, Kakuta T, Tanaka N, et al. Combined pressure and flow measurements to guide treatment of coronary stenoses. JACC Cardiovasc Interv 2021;14:1904–13. https://doi.org/10.1016/j.jcin.2021.07.041 357. van de Hoef TP, Lee JM, Boerhout CKM, de Waard GA, Jung J-H, Lee SH, et al. Combined assessment of FFR and CFR for decision making in coronary revascularization: from the multicenter international ILIAS registry. JACC Cardiovasc Interv 2022;15: 1047–56. https://doi.org/10.1016/j.jcin.2022.03.016 358. van de Hoef TP, Stegehuis VE, Madera-Cambero MI, van Royen N, van der Hoeven NW, de Waard GA, et al. Impact of core laboratory assessment on treatment decisions and clinical outcomes using combined fractional flow reserve and coronary flow reserve measurements—DEFINE-FLOW core laboratory sub-study. Int J Cardiol 2023;377:9–16. https://doi.org/10.1016/j.ijcard.2023.01.009 359. Meuwissen M, Siebes M, Chamuleau SA, van Eck-Smit BLF, Koch KT, de Winter RJ, et al. Hyperemic stenosis resistance index for evaluation of functional coronary lesion severity. Circulation 2002;106:441–6. https://doi.org/10.1161/01.cir.0000023041. 26199.29 360. Boerhout CKM, Echavarria-Pinto M, de Waard GA, et al. Impact of hyperemic stenosis resistance (HSR) on long-term outcomes of stable angina. Eurointervention 2024;20: e699–706. https://doi.org/10.4244/EIJ-D-23-00713 361. De Bruyne B, Pijls NHJ, Gallinoro E, Candreva A, Fournier S, Keulards DCJ, et al. Microvascular resistance reserve for assessment of coronary microvascular function: JACC technology corner. J Am Coll Cardiol 2021;78:1541–9. https://doi.org/10.1016/j. jacc.2021.08.017 362. Candreva A, Gallinoro E, Fernandez Peregrina E, Sonck J, Keulards DCJ, van‘t Veer M, et al. Automation of intracoronary continuous thermodilution for absolute coronary flow and microvascular resistance measurements. Catheter Cardiovasc Interv 2022;100: 199–206. https://doi.org/10.1002/ccd.30244 363. De Bruyne B, Belmonte M, Jabbour JR, Curzen N. Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons. EuroIntervention 2023;19:23–5. https://doi.org/10.4244/EIJ-E-23-00008 364. de Vos A, Jansen TPJ, van ’t Veer M, Dimitriu-Leen A, Konst RE, Elias-Smale S, et al. Microvascular resistance reserve to assess microvascular dysfunction in ANOCA patients. JACC Cardiovasc Interv 2023;16:470–81. https://doi.org/10.1016/j.jcin.2022.12. 012 365. Johnson NP, Gould KL. Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity. JACC Cardiovasc Imaging 2012;5:430–40. https://doi.org/10.1016/j.jcmg.2011.12.014 366. van de Hoef TP, Echavarria-Pinto M, van Lavieren MA, Meuwissen M, Serruys PWJC, Tijssen JGP, et al. Diagnostic and prognostic implications of coronary flow capacity: a comprehensive cross-modality physiological concept in ischemic heart disease. JACC Cardiovasc Interv 2015;8:1670–80. https://doi.org/10.1016/j.jcin.2015.05.032 367. Murai T, Stegehuis VE, van de Hoef TP, Wijntjens GWM, Hoshino M, Kanaji Y, et al. Coronary flow capacity to identify stenosis associated with coronary flow improvement after revascularization: a combined analysis from DEFINE FLOW and IDEAL. J Am Heart Assoc 2020;9:e016130. https://doi.org/10.1161/JAHA.120.016130 368. de Winter RW, Jukema RA, van Diemen PA, Schumacher SP, Driessen RS, Stuijfzand WJ, et al. The impact of coronary revascularization on vessel-specific coronary flow capacity and long-term outcomes: a serial [15O]H2O positron emission tomography perfusion imaging study. Eur Heart J Cardiovasc Imaging 2022;23:743–52. https://doi. org/10.1093/ehjci/jeab263 369. Park SJ, Ahn JM, Kang SJ, Yoon S-H, Koo B-K, Lee J-Y, et al. Intravascular ultrasoundderived minimal lumen area criteria for functionally significant left main coronary artery stenosis. JACC Cardiovasc Interv 2014;7:868–74. https://doi.org/10.1016/j.jcin. 2014.02.015 370. Ziedses des Plantes AC, Scoccia A, Gijsen F, van Soest G, Daemen J. Intravascular imaging-derived physiology-basic principles and clinical application. Interv Cardiol Clin 2023;12:83–94. https://doi.org/10.1016/j.iccl.2022.09.008 371. Noguchi M, Gkargkoulas F, Matsumura M, Kotinkaduwa LN, Hu X, Usui E, et al. Impact of nonobstructive left main coronary artery atherosclerosis on long-term mortality. JACC Cardiovasc Interv 2022;15:2206–17. https://doi.org/10.1016/j.jcin.2022.08.024 372. Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech J-W, van’t Veer M, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007;49:2105–11. https://doi. org/10.1016/j.jacc.2007.01.087 373. Van Belle E, Cosenza A, Baptista SB, Vincent F, Henderson J, Santos L, et al. Usefulness of routine fractional flow reserve for clinical management of coronary artery disease in patients with diabetes. JAMA Cardiol 2020;5:272–81. https://doi.org/10.1001/ jamacardio.2019.5097 374. Xu B, Tu S, Qiao S, Qu X, Chen Y, Yang J, et al. Diagnostic accuracy of angiographybased quantitative flow ratio measurements for online assessment of coronary stenosis. J Am Coll Cardiol 2017;70:3077–87. https://doi.org/10.1016/j.jacc.2017.10.035 375. Westra J, Andersen BK, Campo G, Matsuo H, Koltowski L, Eftekhari A, et al. Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: the FAVOR II Europe-Japan study. J Am Heart Assoc 2018;7:e009603. https://doi.org/10.1161/ JAHA.118.009603 376. Johnson NP, Gould KL, De Bruyne B. Autoregulation of coronary blood supply in response to demand: JACC review topic of the week. J Am Coll Cardiol 2021;77:2335–45. https://doi.org/10.1016/j.jacc.2021.03.293 377. Masdjedi K, van Zandvoort LJC, Balbi MM, Gijsen FJH, Ligthart JMR, Rutten MCM, et al. Validation of a three-dimensional quantitative coronary angiography-based software to calculate fractional flow reserve: the FAST study. EuroIntervention 2020;16:591–9. https://doi.org/10.4244/eij-d-19-00466 378. Pijls NH, De Bruyne B, Smith L, Aarnoudse W, Barbato E, Bartunek J, et al. Coronary thermodilution to assess flow reserve: validation in humans. Circulation 2002;105: 2482–6. https://doi.org/10.1161/01.cir.0000017199.09457.3d 379. Barbato E, Aarnoudse W, Aengevaeren WR, Werner G, Klauss V, Bojara W, et al. Validation of coronary flow reserve measurements by thermodilution in clinical practice. Eur Heart J 2004;25:219–23. https://doi.org/10.1016/j.ehj.2003.11.009 380. Fearon WF, Balsam LB, Farouque HM, Robbins RC, Fitzgerald PJ, Yock PG, et al. Novel index for invasively assessing the coronary microcirculation. Circulation 2003;107: 3129–32. https://doi.org/10.1161/01.Cir.0000080700.98607.D1 381. Fearon WF, Kobayashi Y. Invasive assessment of the coronary microvasculature: the index of microcirculatory resistance. Circ Cardiovasc Interv 2017;10:e005361. https:// doi.org/10.1161/circinterventions.117.005361 382. Gallinoro E, Bertolone DT, Fernandez-Peregrina E, Paolisso P, Bermpeis K, Esposito G, et al. Reproducibility of bolus versus continuous thermodilution for assessment of coronary microvascular function in patients with ANOCA. EuroIntervention 2023;19: e155–66. https://doi.org/10.4244/eij-d-22-00772 383. Mejía-Rentería H, Wang L, Chipayo-Gonzales D, van de Hoef TP, Travieso A, Espejo C, et al. Angiography-derived assessment of coronary microcirculatory resistance in patients with suspected myocardial ischaemia and non-obstructive coronary arteries. EuroIntervention 2023;18:e1348–56. https://doi.org/10.4244/EIJ-D-22-00579 384. Ford TJ, Ong P, Sechtem U, Beltrame J, Camici PG, Crea F, et al. Assessment of vascular dysfunction in patients without obstructive coronary artery disease: why, how, and when. JACC Cardiovasc Interv 2020;13:1847–64. https://doi.org/10.1016/j.jcin.2020.05. 052 385. Radico F, Cicchitti V, Zimarino M, De Caterina R. Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. JACC Cardiovasc Interv 2014;7:453–63. https://doi.org/10.1016/j. jcin.2014.01.157 386. Boerhout CKM, Feenstra RGT, Somsen GA, Appelman Y, Ong P, Beijk MAM, et al. Coronary computed tomographic angiography as gatekeeper for new-onset stable angina. Neth Heart J 2021;29:551–6. https://doi.org/10.1007/s12471-021-01639-7 387. Jukema R, Maaniitty T, van Diemen P, Berkhof H, Raijmakers PG, Sprengers R, et al. Warranty period of coronary computed tomography angiography and [15O]H2O positron emission tomography in symptomatic patients. Eur Heart J Cardiovasc Imaging 2022;24:304–11. https://doi.org/10.1093/ehjci/jeac258 388. Haberkorn SM, Haberkorn SI, Bonner F, Kelm M, Hopkin G, Petersen SE. Vasodilator myocardial perfusion cardiac magnetic resonance imaging is superior to dobutamine stress echocardiography in the detection of relevant coronary artery stenosis: a systematic review and meta-analysis on their diagnostic accuracy. Front Cardiovasc Med 2021;8:630846. https://doi.org/10.3389/fcvm.2021.630846 389. van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin M-F, Bertolotto M, et al. Post-contrast acute kidney injury—Part 1: definition, clinical features, incidence, role of contrast medium and risk factors : recommendations for updated ESUR Contrast Downloaded from academic.oup.com/eurheartj/article/45/36/3415/7743115 by guest on 07 October 2026